Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marlene Carlson"'
Autor:
Leah M. Fleming, Daniel C. Javitt, Cameron S. Carter, Joshua T. Kantrowitz, Ragy R. Girgis, Lawrence S. Kegeles, John D. Ragland, Richard J. Maddock, Tyler A. Lesh, Costin Tanase, James Robinson, William Z. Potter, Marlene Carlson, Melanie M. Wall, Tse-Hwei Choo, Jack Grinband, Jeffrey Lieberman, John H. Krystal, Philip R. Corlett
Publikováno v:
NeuroImage: Clinical, Vol 22, Iss , Pp - (2019)
Ketamine is an uncompetitive N-methyl-d-aspartate (NMDA) glutamate receptor antagonist. It induces effects in healthy individuals that mimic symptoms associated with schizophrenia. We sought to root these experiences in altered brain function, specif
Externí odkaz:
https://doaj.org/article/11febe31fb8443d1b081e08d479a69f3
Autor:
Elizabeth Deckler, Melissa Ferland, Stephanie Brazis, Megan R Mayer, Marlene Carlson, Joshua T Kantrowitz
Publikováno v:
International Journal of Neuropsychopharmacology. 25:924-932
Background With numerous potentially novel targets and pharmacodynamic biomarkers for schizophrenia entering late-stage testing, the next decade will bring an urgent need for well-conducted clinical trials. A critically important step for the success
Autor:
Pejman Sehatpour, Dan V. Iosifescu, Heloise M. De Baun, Constance Shope, Megan R. Mayer, James Gangwisch, Elisa Dias, Tarek Sobeih, Tse-Hwei Choo, Melanie M. Wall, Alice Medalia, Alice M. Saperstein, Lawrence S. Kegeles, Ragy R. Girgis, Marlene Carlson, Joshua T. Kantrowitz
Publikováno v:
Biological Psychiatry.
Autor:
Daniel C. Javitt, Marlene Carlson, David H. Margolin, Nicola Brice, Anna Beloborodova, Heloise M. De Baun, Joshua T. Kantrowitz, Pejman Sehatpour, Mark Carlton
Publikováno v:
Neuropsychopharmacology
Serotonin type-3 receptor (5-HT(3)R) antagonists show potential as a treatment for cognitive deficits in schizophrenia. CVN058, a brain-penetrant, potent and selective 5-HT(3)R antagonist, shows efficacy in rodent models of cognition and was well-tol
Autor:
Christian G. Kohler, Daniel H. Wolf, Anissa Abi-Dargham, Alan Anticevic, Youngsun T. Cho, Clara Fonteneau, Roberto Gil, Ragy R. Girgis, David L. Gray, Jack Grinband, Jonathan A. Javitch, Joshua T. Kantrowitz, John H. Krystal, Jeffrey A. Lieberman, John D. Murray, Mohini Ranganathan, Nicole Santamauro, Jared X. Van Snellenberg, Zailyn Tamayo, Ruben C. Gur, Raquel E. Gur, Monica E. Calkins, Deepak D'Souza, Vinod Srihari, Ralitza Gueorguieva, Prashant Patel, Kimberlee Forselius-Bielen, Jing Lu, Audrey Butler, Geena Fram, Yvette Afriyie-Agyemang, Alexandria Selloni, Laura Cadavid, Sandra Gomez-Luna, Aarti Gupta, Rajiv Radhakrishnan, Ali Rashid, Ryan Aker, Philisha Abrahim, Anahita Bassir Nia, Toral Surti, Lawrence S. Kegeles, Marlene Carlson, Terry Goldberg, James Gangwisch, Erinne Benedict, Preetika Govil, Stephanie Brazis, Megan Mayer, Nathalie de la Garrigue, Natalka Fallon, Topaz Baumvoll, Sameera Abeykoon, Greg Perlman, Kelly Bobchin, Mark Elliott, Lyndsay Schmidt, Sage Rush, Allison Port, Zac Heffernan, Nina Laney, Jenna Kantor, Thomas Hohing
Publikováno v:
Biological Psychiatry Global Open Science.
Autor:
Pejman Sehatpour, Daniel Javitt, Heloise De Baun, Marlene Carlson, David Margolin, Mark Carlton, Nicola Brice, Joshua Kantrowitz
Serotonin type-3 receptor (5-HT3R) antagonists show potential as a treatment for cognitive deficits in schizophrenia. CVN058, a brain-penetrant, potent and selective 5-HT3R antagonist, shows efficacy in rodent models of cognition and was well-tolerat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::820f33bed5769c9141d6bb8ad357f5fe
https://doi.org/10.21203/rs.3.rs-525748/v1
https://doi.org/10.21203/rs.3.rs-525748/v1
Autor:
Natalie, de la Garrigue, Juliana, Glasser, Pejman, Sehatpour, Dan V, Iosifescu, Elisa, Dias, Marlene, Carlson, Constance, Shope, Tarek, Sobeih, Tse-Hwei, Choo, Melanie M, Wall, Lawrence S, Kegeles, James, Gangwisch, Megan, Mayer, Stephanie, Brazis, Heloise M, De Baun, Stephanie, Wolfer, Dalton, Bermudez, Molly, Arnold, Danielle, Rette, Amir M, Meftah, Melissa, Conant, Jeffrey A, Lieberman, Joshua T, Kantrowitz
Publikováno v:
Journal of psychiatry and brain science
We report on the rationale and design of an ongoing NIMH sponsored R61-R33 project in schizophrenia/schizoaffective disorder. This project studies augmenting the efficacy of auditory neuroplasticity cognitive remediation (AudRem) with d-serine, an N-
Autor:
Tse-Hwei Choo, Robert Freedman, Jeffrey A. Lieberman, Blair Vail, Lawrence S. Kegeles, Marlene Carlson, Jack Grinband, Joshua T. Kantrowitz, Pejman Sehatpour, Tarek Sobeih, Melanie M. Wall, Daniel C. Javitt
Publikováno v:
Neuropsychopharmacology
Despite their theoretical rationale, nicotinic alpha-7 acetylcholine (nα(7)) receptor agonists, have largely failed to demonstrate efficacy in placebo-controlled trials in schizophrenia. AVL-3288 is a nα(7) positive allosteric modulator (PAM), whic
Autor:
Marlene Carlson, Jack Grinband, Daniel C. Javitt, Leah Fleming, Jeffrey A. Lieberman, Melanie M. Wall, Richard J. Maddock, John H. Krystal, Tse Hwei Choo, Tyler A. Lesh, James Robinson, Costin Tanase, John D Ragland, Ragy R. Girgis, Lawrence S. Kegeles, Joshua T. Kantrowitz, William Z. Potter, Philip R. Corlett, Cameron S. Carter
Publikováno v:
NeuroImage: Clinical, Vol 22, Iss, Pp-(2019)
Fleming, Leah M; Javitt, Daniel C; Carter, Cameron S; Kantrowitz, Joshua T; Girgis, Ragy R; Kegeles, Lawrence S; et al.(2019). A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanisms. NeuroImage: Clinical, 22, 101739-101739. doi: 10.1016/j.nicl.2019.101739. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/72t6646j
NeuroImage : Clinical
Fleming, Leah M; Javitt, Daniel C; Carter, Cameron S; Kantrowitz, Joshua T; Girgis, Ragy R; Kegeles, Lawrence S; et al.(2019). A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanisms. NeuroImage: Clinical, 22, 101739-101739. doi: 10.1016/j.nicl.2019.101739. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/72t6646j
NeuroImage : Clinical
Ketamine is an uncompetitive N-methyl-d-aspartate (NMDA) glutamate receptor antagonist. It induces effects in healthy individuals that mimic symptoms associated with schizophrenia. We sought to root these experiences in altered brain function, specif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::129e54a1eb6b31ab61cefac81ff6924f
https://escholarship.org/uc/item/72t6646j
https://escholarship.org/uc/item/72t6646j
Autor:
Pejman Sehatpour, Lee Dawson, Daniel C. Javitt, David H. Margolin, Heloise M. De Baun, Mark Carlton, Roland Bürli, Nicola Brice, Marlene Carlson, Joshua T. Kantrowitz
Publikováno v:
Biological Psychiatry. 89:S27